Amicus Therapeutics, Inc.
Simbol: FOLD
NASDAQ
10.4
USDPrețul de piață astăzi
-20.1432
Raportul P/E
-0.2119
Raportul PEG
3.08B
MRK Cap
- 0.00%
Randament DIV
Amicus Therapeutics, Inc. (FOLD) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1099.23 | 286.2 | 293.6 | 482.5 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 217.01 | 39.2 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 292.86 | 87.6 | 66.2 | 52.7 | ||||||||||||||||||||
balance-sheet.row.inventory | 195.02 | 59.7 | 23.8 | 26.8 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 191.73 | 49.5 | 40.2 | 34.8 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 1778.84 | 483.1 | 423.8 | 596.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 236.73 | 58 | 60.3 | 63.1 | ||||||||||||||||||||
balance-sheet.row.goodwill | 791.19 | 197.8 | 197.8 | 197.8 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 86.92 | 20.5 | 23 | 23 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 878.11 | 218.3 | 220.8 | 220.8 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 13.44 | 3.1 | 4.3 | -4.9 | ||||||||||||||||||||
balance-sheet.row.tax-assets | -10.36 | 0 | 4.9 | 4.9 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 75.82 | 15.5 | 10 | 24.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1193.74 | 294.8 | 300.4 | 308.3 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.account-payables | 76.76 | 15.1 | 15.4 | 21.5 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 31.93 | 8.3 | 8.6 | 7.4 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 12.43 | 12.4 | 5.9 | 6.2 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1722.72 | 387.9 | 443.6 | 432.7 | ||||||||||||||||||||
Deferred Revenue Non Current | 17.72 | 0 | 4.7 | 7.3 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | -17.72 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 513.63 | 131.8 | 110.1 | 117.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1830.25 | 450 | 462.1 | 451.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 227.27 | 48.9 | 60.1 | 50.8 | ||||||||||||||||||||
balance-sheet.row.total-liab | 2465.01 | 617.7 | 601.1 | 597.8 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 6.77 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 11.48 | 2.9 | 2.8 | 2.8 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -10548.38 | -2684.1 | -2532.5 | -2295.9 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.04 | 5.3 | -12.1 | 5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 11041.73 | 2836 | 2664.8 | 2595.5 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2972.58 | - | - | - | ||||||||||||||||||||
Total Investments | 220.09 | 42.3 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.total-debt | 1803.53 | 445.1 | 452.1 | 440.1 | ||||||||||||||||||||
balance-sheet.row.net-debt | 921.3 | 198.1 | 303.3 | 194.9 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 7.87 | 7.9 | 5.3 | 6.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -9.97 | -4.9 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 86.08 | 86.1 | 76.5 | 57.8 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -40.05 | -48 | -39.9 | -18.6 | |||||||||||||||||||
cash-flows.row.account-receivables | -20.11 | -20.1 | -17.3 | -8.2 | |||||||||||||||||||
cash-flows.row.inventory | -44.61 | -44.6 | -5.3 | -7.8 | |||||||||||||||||||
cash-flows.row.account-payables | 49.19 | 49.2 | -6.4 | 7.4 | |||||||||||||||||||
cash-flows.row.other-working-capital | -24.53 | -32.5 | -10.8 | -10 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 38.57 | 41.5 | 28 | 2.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -69.09 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -12.2 | 0 | 3.4 | 3.9 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -91.72 | -91.7 | -243.3 | -341.4 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 197.23 | 197.2 | 335.9 | 424 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 12.2 | 0 | 0 | -3.9 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 98.06 | 98.1 | 92.3 | 78.8 | |||||||||||||||||||
cash-flows.row.debt-repayment | -20.96 | -21 | -0.3 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 95.35 | 103.2 | 4.3 | 199.8 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -17.92 | 0 | -11.5 | -15 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -4.3 | -15 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 7.19 | -20.6 | 4.3 | 42.8 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 61.68 | 61.7 | -7.5 | 212.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 6.31 | 6.3 | -14.6 | -5 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 96.83 | 98.2 | -96.3 | 83.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 892.58 | 247 | 153.1 | 249.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 795.75 | 148.8 | 249.5 | 166.2 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -69.09 | -69.1 | -166.6 | -202.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -76.53 | -76.5 | -170.3 | -206.4 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 399.36 | 399.4 | 329.2 | 305.5 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 39.51 | 45.2 | 38.6 | 34.5 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 359.85 | 354.2 | 290.6 | 271 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 152.38 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 431.11 | 427.7 | 495.1 | 471 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 470.62 | 472.9 | 533.7 | 505.4 | |||||||||||||||||||||
income-statement-row.row.interest-income | 7.08 | 7.1 | 3 | 0.5 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4.13 | 7.9 | 12.5 | 3.8 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -94.93 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -76.96 | -73.5 | -204.4 | -199.9 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -150.1 | -150.1 | -242 | -241.6 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.74 | 1.5 | -5.5 | 8.9 | |||||||||||||||||||||
income-statement-row.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 |
Întrebări frecvente
Ce este Amicus Therapeutics, Inc. (FOLD) totalul activelor?
Amicus Therapeutics, Inc. (FOLD) activele totale sunt 777880000.000.
Care este venitul anual al întreprinderii?
Venitul anual este 218583000.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.901.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -0.261.
Care este marja de profit net a întreprinderii?
Marja profitului net este -0.380.
Care este venitul total al întreprinderii?
Venitul total este -0.193.
Care este Amicus Therapeutics, Inc. (FOLD) profitul net (venitul net)?
Profitul net (venitul net) este -151584000.000.
Care este datoria totală a firmei?
Datoria totală este 445059000.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 427651000.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 246994000.000.